Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDGL Madrigal Pharmaceuticals, Inc.

盘后交易 05-02 18:41:40 EDT

315.48

-12.22

-3.73%

盘后315.51

+0.03+0.01%

18:34 EDT

最高337.52	最低313.42	成交量59.23万
今开329.86	昨收327.70	日振幅7.35%
总市值69.66亿	流通市值35.83亿	总股本2,208万
成交额1.89亿	换手率5.22%	流通股本1,136万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals, Inc.","latestPrice":315.48,"timestamp":1746216000000,"preClose":327.7,"halted":0,"volume":592315,"hourTrading":{"tag":"盘后","latestPrice":315.51,"preClose":315.48,"latestTime":"18:34 EDT","volume":7160,"amount":2258907.8988,"timestamp":1746225263922},"delay":0,"floatShares":11356334,"shares":22080246,"eps":-21.900663,"marketStatus":"盘后交易","change":-12.22,"latestTime":"05-02 18:41:40 EDT","open":329.86,"high":337.52,"low":313.42,"amount":188914734.8913,"amplitude":0.073543,"askPrice":330.87,"askSize":1,"bidPrice":312.5,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-21.900663,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":327.7,"preHourTrading":{"tag":"盘前","latestPrice":336.15,"preClose":327.7,"latestTime":"09:25 EDT","volume":37,"amount":12309.1193,"timestamp":1746192300042},"postHourTrading":{"tag":"盘后","latestPrice":315.51,"preClose":315.48,"latestTime":"18:34 EDT","volume":7160,"amount":2258907.8988,"timestamp":1746225263922},"volumeRatio":1.346211,"impliedVol":0.5051,"impliedVolPercentile":0.14},"requestUrl":"/m/hq/s/MDGL/wiki","defaultTab":"wiki","newsList":[{"id":"2532245588","title":"B. Riley Securities：重申Madrigal Pharmaceuticals评级，由买入调整至买入评级, 目标价由422.00美元调整至460.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532245588","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532245588?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:11","pubTimestamp":1746202319,"startTime":"0","endTime":"0","summary":"B. Riley Securities：重申Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由422.00美元调整至460.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050300181094ead825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050300181094ead825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"2532639829","title":"加拿大投资银行集团：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由394.00美元调整至420.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532639829","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532639829?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:55","pubTimestamp":1746201313,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由394.00美元调整至420.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02235550109627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MDGL"],"gpt_icon":0},{"id":"1189122804","title":"异动解读 | Madrigal Pharmaceuticals股价盘中大跌5.73%，尽管季度业绩优于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1189122804","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189122804?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:48","pubTimestamp":1746107339,"startTime":"0","endTime":"0","summary":"生物制药公司Madrigal Pharmaceuticals, Inc.今日盘中股价大跌5.73%，引起市场广泛关注。这一显著跌幅出现在公司发布2025年第一季度财报之后，尽管财报数据优于分析师预期。然而，尽管业绩超出预期，Madrigal Pharmaceuticals本季度仍录得7324万美元的亏损。股价下跌似乎与财报数据相悖，这可能反映出投资者对公司长期财务状况的担忧。尽管公司业绩优于预期，但持续的亏损可能引发了市场对其未来盈利能力的质疑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Madrigal Pharmaceuticals股价盘中大跌5.73%，尽管季度业绩优于预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MDGL"],"gpt_icon":0},{"id":"2532008028","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.59%报315.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008028?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:32","pubTimestamp":1746106363,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时32分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.59%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213243aa2c8054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213243aa2c8054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","MDGL"],"gpt_icon":0},{"id":"2529793158","title":"Madrigal Pharmaceuticals, Inc.跌2.85% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2529793158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529793158?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:40","pubTimestamp":1745502032,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时40分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速跳水2.85%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242140329743aa59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242140329743aa59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2529802511","title":"Madrigal Pharmaceuticals, Inc.跌2.40% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529802511?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:31","pubTimestamp":1745242306,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时31分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速跳水2.40%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213146a4611ca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213146a4611ca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","MDGL"],"gpt_icon":0},{"id":"2528741275","title":"Madrigal Pharmaceuticals, Inc.跌2.53% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528741275?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:37","pubTimestamp":1744900675,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时37分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速下挫2.53%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417223755973b629e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417223755973b629e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","MDGL"],"gpt_icon":0},{"id":"2527245288","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527245288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527245288?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:31","pubTimestamp":1744810281,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时31分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.28%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213122aa2c7139&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213122aa2c7139&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2517118936","title":"Madrigal Pharmaceuticals, Inc.盘中异动 临近收盘急速跳水5.01%报329.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517118936?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:58","pubTimestamp":1741294732,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时58分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报329.89美元/股，成交量23.1556万股，换手率1.05%，振幅5.68%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045853a262ecd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045853a262ecd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","MDGL"],"gpt_icon":0},{"id":"2517946676","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517946676?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:45","pubTimestamp":1741189531,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时45分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.02%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc 是一家生物制药公司，专注于提供代谢功能障碍相关脂肪性肝炎  的新型疗法，这是一种严重的肝病，具有高度未满足的医疗需求，可能导致肝硬化、肝功能衰竭和过早死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234531a260dd65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234531a260dd65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","MDGL"],"gpt_icon":0},{"id":"2516603054","title":"Madrigal Pharmaceuticals, Inc.跌4.30% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2516603054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516603054?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:18","pubTimestamp":1741101533,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时18分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速跳水4.30%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1171.70%、1133.53%、680.05%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为66.03%、66.02%、64.44%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231853abe7fdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231853abe7fdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2516634270","title":"Madrigal Pharmaceuticals, Inc.盘中异动 急速下挫5.35%报323.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634270?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:48","pubTimestamp":1741013289,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时48分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.35%。截至发稿，该股报323.02美元/股，成交量3.3061万股，换手率0.15%，振幅3.05%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Geovax Labs, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为368.92%、109.98%、69.27%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为140.46%、68.30%、24.83%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224810989a1449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224810989a1449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","MDGL","BK4139"],"gpt_icon":0},{"id":"2516548069","title":"Madrigal Pharmaceuticals, Inc.2024财年实现净利润-4.66亿美元，同比减少24.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516548069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516548069?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931237,"startTime":"0","endTime":"0","summary":"3月3日，Madrigal Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-4.66亿美元，同比减少24.60%；其中营业收入为1.80亿美元，每股基本收益为-21.90美元。从资产负债表来看，Madrigal Pharmaceuticals, Inc.总负债2.88亿美元，其中短期债务983000.00美元，资产负债比为3.62，流动比率为6.12。机构评级：截至2025年3月3日，当前有16家机构对Madrigal Pharmaceuticals, Inc.目标价做出预测，其中目标均价为411.31美元，其中最低目标价为239.00美元，最高目标价为544.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000057abe4aca4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000057abe4aca4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"2514332004","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332004?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:43","pubTimestamp":1740688985,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时43分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.18%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1943.02%、410.26%、197.12%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044306abdfbfc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044306abdfbfc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2514394334","title":"花旗：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由378.00美元调整至469.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514394334","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514394334?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:31","pubTimestamp":1740684698,"startTime":"0","endTime":"0","summary":"花旗：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由378.00美元调整至469.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28033148442056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MDGL"],"gpt_icon":0},{"id":"1102872556","title":"异动解读 | MDGL公布罕见好于预期财报 股价盘中大涨8.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102872556","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102872556?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:40","pubTimestamp":1740580847,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals今日盘中大涨8.24%,引发了市场的广泛关注。这主要源于公司公布了一组罕见的好于市场预期的2024年第四季度财报。与上年同期相比,MDGL的营收和利润均出现了明显改善。出色的财报传递出MDGL经营向好、业务状况改善的利好信号,这不仅提振了投资者对公司长期增长前景的信心,也证明公司在生物医药行业的发展步伐正在加快。MDGL股价盘中大涨8.24%,正是充分体现了投资者对公司前景的看涨预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MDGL"],"gpt_icon":0},{"id":"2514186856","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘急速拉升8.80%报336.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514186856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514186856?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580332,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速拉升8.80%。截至发稿，该股报336.74美元/股，成交量9912股，换手率0.05%，振幅1.54%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2798.65%、116.09%、90.30%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为29.66%、16.86%、14.35%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223212a254f696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223212a254f696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"1179187165","title":"异动解读 | 马德里加尔制药公司发布2024年第四季度业绩佳绩，盘前涨幅6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179187165","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179187165?lang=zh_cn&edition=full","pubTime":"2025-02-26 21:50","pubTimestamp":1740577857,"startTime":"0","endTime":"0","summary":"今日盘前，马德里加尔制药公司(MDGL)股价出现大涨6.63%的行情，引起了市场的广泛关注。\n\n导致该股价大涨的主要原因是，公司在昨日发布的2024年第四季度财报数据优于市场预期。具体来看，马德里加尔制药公司在本季度实现营收1.033亿美元，高于预期的9125万美元；此外，每股盈利亏损2.71美元，优于预期亏损4.12美元。与去年同期相比，公司的营收和净利润均出现了大幅改善。\n\n得益于这组出色的财报数据，投资者对马德里加尔制药公司未来的增长前景更加看好，从而推动了今日盘前股价的大涨。公司的优异表现将为其在生物医药行业的持续发展注入新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MDGL"],"gpt_icon":0},{"id":"2514983486","title":"Madrigal Pharmaceuticals(MDGL.US)：2024年Q4财报实现营收1.033亿美元，前值为0美元，预期值为9125万美元；每股收益为-2.71美元，前值为-5.68美元，预期值为-4.12美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514983486","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514983486?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:25","pubTimestamp":1740572734,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals(MDGL.US)：2024年Q4财报实现营收1.033亿美元，前值为0美元，预期值为9125万美元；每股收益为-2.71美元，前值为-5.68美元，预期值为-4.12美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26202548411178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MDGL"],"gpt_icon":0},{"id":"1194341586","title":"马德里加尔制药公司2024年第四季度GAAP每股收益$(2.71)优于预期$(4.16)，销售额为1.0322亿美元优于预期的9856万美元，现金及现金等价物为9.313亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194341586","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194341586?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:11","pubTimestamp":1740571892,"startTime":"0","endTime":"0","summary":"马德里加尔制药公司报告季度每股亏损$，优于分析师预期的$，增幅为34.86%。与去年同期每股亏损$相比，这是一个52.29%的提升。公司报告季度销售额为1.0322亿美元，优于分析师预期的9856万美元，增幅为4.73%。以上内容来自Benzinga Earnings专栏，原文如下：Madrigal Pharmaceuticals  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 34.86 percent. This is a 52.29 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $103.22 million which beat the analyst consensus estimate of $98.56 million by 4.73 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"马德里加尔制药公司2024年第四季度GAAP每股收益$(2.71)优于预期$(4.16)，销售额为1.0322亿美元优于预期的9856万美元，现金及现金等价物为9.313亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0115},{"period":"3month","weight":-0.0212},{"period":"6month","weight":0.0254},{"period":"1year","weight":0.5561},{"period":"ytd","weight":0.062}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司，致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命，包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.038123},{"month":2,"riseRate":0.777778,"avgChangeRate":0.080513},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.037813},{"month":4,"riseRate":0.555556,"avgChangeRate":0.008622},{"month":5,"riseRate":0.333333,"avgChangeRate":0.147998},{"month":6,"riseRate":0.625,"avgChangeRate":0.024173},{"month":7,"riseRate":0.125,"avgChangeRate":-0.088753},{"month":8,"riseRate":0.555556,"avgChangeRate":0.058165},{"month":9,"riseRate":0.333333,"avgChangeRate":0.13282},{"month":10,"riseRate":0.666667,"avgChangeRate":0.070394},{"month":11,"riseRate":0.555556,"avgChangeRate":0.062808},{"month":12,"riseRate":0.444444,"avgChangeRate":0.416281}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals, Inc.","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Madrigal Pharmaceuticals, Inc.,MDGL,Madrigal Pharmaceuticals, Inc.股票,Madrigal Pharmaceuticals, Inc.股票老虎,Madrigal Pharmaceuticals, Inc.股票老虎国际,Madrigal Pharmaceuticals, Inc.行情,Madrigal Pharmaceuticals, Inc.股票行情,Madrigal Pharmaceuticals, Inc.股价,Madrigal Pharmaceuticals, Inc.股市,Madrigal Pharmaceuticals, Inc.股票价格,Madrigal Pharmaceuticals, Inc.股票交易,Madrigal Pharmaceuticals, Inc.股票购买,Madrigal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}